WALTHAM, Mass.--(BUSINESS WIRE)--
PerkinElmer,
Inc. (NYSE:PKI), a global leader focused on improving the health and
safety of people and the environment, today announced that the Company
will present at the Bio-IT World Conference at 11:00AM eastern time on
Wednesday, April 10, 2013 at the Seaport World Trade Center located at
200 Seaport Boulevard in Boston, MA.
Kevin Hrusovsky, president of PerkinElmer's Life Sciences &Technology
business, will be a featured speaker at the Bio-IT World Conference's
Cancer Informatics track. In his Tools for Revolutionizing
Translational Cancer Medicine presentation, Mr. Hrusovsky will
discuss how combining the "in vitro-to-in vivo-to human" continuum of
research tools with a powerful informatics platform may successfully
bridge the chasm from laboratory research to clinical applications,
particularly in the field of cancer medicine and personalized health.
For more information, visit the Bio-IT
World Conference website.
About PerkinElmer
PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The company reported revenue of
approximately $2.1 billion in 2012, has about 7,500 employees serving
customers in more than 150 countries, and is a component of the S&P 500
Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
Edelman (on behalf of PerkinElmer)
Paul Barren, 404-460-9679
Paul.barren@edelman.com
Source: PerkinElmer, Inc.
News Provided by Acquire Media